Recently, PRIMA-1Met, also known as APR-246, propels both Vem-sensitive and Vem-resistant melanoma cells to apoptotic cell death via directly activating p53 and indirectly inhibiting PI3K/AKT pathway (Krayem et al., 2016). This evidence concerns the gene AKT1 and melanoma.